Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection

被引:11
作者
Jensen, T. O. [1 ,2 ]
Darley, D. R. [3 ]
Goeman, E. E. [4 ]
Shaw, K. [5 ,6 ]
Marriott, D. J. [1 ,4 ]
Glanville, A. R. [2 ]
机构
[1] St Vincents Hosp, Dept Infect Dis, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia
[3] St Vincents Hosp, Lung Transplant Unit, Sydney, NSW, Australia
[4] St Vincents Hosp, Dept Microbiol, Sydpath, Sydney, NSW, Australia
[5] South Eastern Sydney Local Hlth Dist, TB Program, Sydney, NSW, Australia
[6] St Vincents Hosp, Sydney, NSW, Australia
关键词
lung transplantation; tuberculosis; latent infection; isoniazid resistance;
D O I
10.1111/tid.12580
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Donor-derived tuberculosis (TB) is an increasingly recognized complication of solid organ transplantation. We report a case of isoniazid-resistant pulmonary TB in a lung transplant recipient. The patient acquired the infection from the lung donor who was previously empirically treated with isoniazid for latent TB. The case highlights the caveat that, while adequate treatment of latent TB with isoniazid is presumed, meticulous screening of donors is required.
引用
收藏
页码:782 / 784
页数:3
相关论文
共 10 条
[1]   Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology [J].
Aguado, Jose Maria ;
Torre-Cisneros, Julian ;
Fortun, Jesus ;
Benito, Natividad ;
Meije, Yolanda ;
Doblas, Antonio ;
Munoz, Patricia .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (09) :1276-1284
[2]  
[Anonymous], REP TUB US 2013
[3]  
[Anonymous], 2010, WHO/HTM/TB/2010.3
[4]   Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994-2009 [J].
Jenkins, Helen E. ;
Zignol, Matteo ;
Cohen, Ted .
PLOS ONE, 2011, 6 (07)
[5]   Donor-Derived Tuberculosis (TB) Infection in Lung Transplant Despite Following Recommended Algorithm [J].
Kumar, D. ;
Budev, M. ;
Koval, C. ;
Hellinger, W. C. ;
Gordon, S. M. ;
Tomford, J. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (08) :2225-2226
[6]   Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections [J].
Len, O. ;
Garzoni, C. ;
Lumbreras, C. ;
Molina, I. ;
Meije, Y. ;
Pahissa, A. ;
Grossi, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 :10-18
[7]  
Lumb R, 2013, COMMUN DIS INTELL, V37, pE40
[8]   Diagnosis and Management of Tuberculosis in Transplant Donors: A Donor-Derived Infections Consensus Conference Report [J].
Morris, M. I. ;
Daly, J. S. ;
Blumberg, E. ;
Kumar, D. ;
Sester, M. ;
Schluger, N. ;
Kim, S. -H. ;
Schwartz, B. S. ;
Ison, M. G. ;
Humar, A. ;
Singh, N. ;
Michaels, M. ;
Orlowski, J. P. ;
Delmonico, F. ;
Pruett, T. ;
John, G. T. ;
Kotton, C. N. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) :2288-2300
[9]   Three cases of donor-derived pulmonary tuberculosis in lung transplant recipients and review of 12 previously reported cases: opportunities for early diagnosis and prevention [J].
Mortensen, E. ;
Hellinger, W. ;
Keller, C. ;
Cowan, L. S. ;
Shaw, T. ;
Hwang, S. ;
Pegues, D. ;
Ahmedov, S. ;
Salfinger, M. ;
Bower, W. A. .
TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (01) :67-75
[10]   Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection [J].
Sterling, Timothy R. ;
Villarino, M. Elsa ;
Borisov, Andrey S. ;
Shang, Nong ;
Gordin, Fred ;
Bliven-Sizemore, Erin ;
Hackman, Judith ;
Hamilton, Carol Dukes ;
Menzies, Dick ;
Kerrigan, Amy ;
Weis, Stephen E. ;
Weiner, Marc ;
Wing, Diane ;
Conde, Marcus B. ;
Bozeman, Lorna ;
Horsburgh, C. Robert, Jr. ;
Chaisson, Richard E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23) :2155-2166